Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Not Yet Recruiting

G-Pola-ZLP in Diffuse Large B-Cell Lymphoma

NCT06665217

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

NCT07113496

Conditions: B-cell Acute Lymphoblastic Leukemia (B-ALL), Blood Protein Disorders, Burkitt Lymphoma, +34 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation

NCT07117305

Conditions: CD7+ Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The First Affiliated Hospital of Zhengzhou University, Department of Oncology Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

Evaluating Near-infrared Spectroscopy Devices for Monitoring Traumatic Brain Injury

NCT07106216

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

PGx Medication Safety Reviews of Persons With IDD

NCT07092852

Conditions: Developmental Disabilities, Developmental Disability, Hemic and Lymphatic Diseases, +19 more
Locations: GalenusRx, Inc. Montverde, Florida, United States

CP Unlimited The Bronx, New York, United States

View Trial Details

Not Yet Recruiting

Golidocitinib With Azacitidine and Chidamide in Patients With Peripheral T-cell Lymphoma.

NCT07081607

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

NCT07068906

Conditions: B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: China Institute of Hematology and Blood Diseases Hospital Tianjin, China

View Trial Details

Not Yet Recruiting

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

NCT06385522

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Long-term Assessment of Chlormethine Gel in Mycosis Fungoides

NCT07046663

Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy

SC Dermatologia, ASST-Papa Giovanni XXIII, Bergamo, Italy

UO Dermatologia - IRCCS Policlinico S.Orsola-Malpighi Bologna, Italy

UO Dermatologia ASST Spedali Civili Brescia Brescia, Italy

View all 20 locations

View Trial Details

Not Yet Recruiting

CD30 CAR-T in the Treatment of CD30 Positive Lymphoma

NCT07048353

Conditions: B Cell Lymphoma, CD30+ Peripheral T-cell Lymphoma, Hemic and Lymphatic Diseases, +9 more
Locations: Tongji Hospital Affiliated to Tongji Medical College of HUST Wuhan, Hubei, China

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions